查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1721213

週边动脉疾病治疗市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Peripheral Arterial Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 245 Pages | 商品交期: 2-10个工作天内

价格

週边动脉疾病治疗市场-报告范围

TMR 关于全球週边动脉疾病治疗市场的报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2019 年至 2035 年期间全球週边动脉疾病治疗市场的收入，以 2025 年为基准年，2035 年为预测年。报告中也提供了2025年至2035年全球週边动脉疾病治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初步研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了访谈。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解週边动脉疾病治疗市场。

市场概况
2024 年的市场价值 29亿美元
2035年的市场价值 64亿美元
复合年增长率 7.5%

该报告深入探讨了全球週边动脉疾病治疗市场的竞争格局。我们已经确定了在全球週边动脉疾病治疗市场中运作的关键参与者，并根据各种属性对每个参与者进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告介绍的全球週边动脉疾病治疗市场参与者的属性。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球週边动脉疾病治疗市场分析与预测

第五章：关键见解

  • 主要地区/国家的监管格局
  • 市场趋势
  • 波特五力分析
  • PESTEL分析
  • 最终用户的关键购买指标
  • 品牌和定价分析
  • 治疗演算法
  • 重要产业活动

第六章：全球市场分析与预测：依药物类型

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年药品市场价值预测
    • 抗血小板药物
    • 降胆固醇药物（他汀类药物）
    • 抗高血压药物
    • 降血压药
    • 血管扩张剂
    • 其他的
  • 不同药物类型的市场吸引力

第七章：全球市场分析与预测：依管理途径

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年按给药途径分類的市场价值预测
    • 口服
    • 肠外
  • 按给药途径分類的市场吸引力

第八章：全球市场分析与预测：按配销通路

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年配销通路市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
  • 配销通路的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第十二章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太其他地区

第十三章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024 年）
  • 公司简介
    • Bayer AG
    • Pfizer Inc.
    • Eli Lilly and Company
    • Cipla
    • Lupin
    • Viatris Inc
    • Johnson & Johnson Services, Inc.
    • Sanofi
    • Novartis AG
    • Amgen Inc.
    • Aurobindo Pharma Limited
    • Other Prominent Players
Product Code: TMRGL86559

Peripheral Arterial Disease Treatment Market - Scope of Report

TMR's report on the global peripheral arterial disease treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peripheral arterial disease treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral arterial disease treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peripheral arterial disease treatment market.

Market Snapshot
Market Value in 2024US$ 2.9 Bn
Market Value in 2035US$ 6.4 Bn
CAGR7.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral arterial disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral arterial disease treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral arterial disease treatment market.

The report delves into the competitive landscape of the global peripheral arterial disease treatment market. Key players operating in the global peripheral arterial disease treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral arterial disease treatment market profiled in this report.

Key Questions Answered in Global peripheral arterial disease treatment market Report:

  • What is the sales/revenue generated by peripheral arterial disease treatment across all regions during the forecast period?
  • What are the opportunities in the global peripheral arterial disease treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Peripheral Arterial Disease Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global peripheral arterial disease treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peripheral arterial disease treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral arterial disease treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Peripheral Arterial Disease Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Landscape across Key Regions / Countries
  • 5.2. Market Trends
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTEL Analysis
  • 5.5. Key Purchase Metrics for End-users
  • 5.6. Brand and Pricing Analysis
  • 5.7. Treatment Algorithm
  • 5.8. Key Industry Events

6. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2035
    • 6.3.1. Antiplatelet Drugs
    • 6.3.2. Cholesterol-Lowering Drugs (Statins)
    • 6.3.3. Anti-hypertensive Drugs
    • 6.3.4. Blood Pressure Medications
    • 6.3.5. Vasodilators
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Drug Type

7. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Oral
    • 7.3.2. Parenteral
  • 7.4. Market Attractiveness By Route of Administration

8. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Type, 2020-2035
    • 10.2.1. Antiplatelet Drugs
    • 10.2.2. Cholesterol-Lowering Drugs (Statins)
    • 10.2.3. Anti-hypertensive Drugs
    • 10.2.4. Blood Pressure Medications
    • 10.2.5. Vasodilators
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2035
    • 10.3.1. Oral
    • 10.3.2. Parenteral
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2035
    • 11.2.1. Antiplatelet Drugs
    • 11.2.2. Cholesterol-Lowering Drugs (Statins)
    • 11.2.3. Anti-hypertensive Drugs
    • 11.2.4. Blood Pressure Medications
    • 11.2.5. Vasodilators
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020-2035
    • 11.3.1. Oral
    • 11.3.2. Parenteral
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2035
    • 12.2.1. Antiplatelet Drugs
    • 12.2.2. Cholesterol-Lowering Drugs (Statins)
    • 12.2.3. Anti-hypertensive Drugs
    • 12.2.4. Blood Pressure Medications
    • 12.2.5. Vasodilators
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Oral
    • 12.3.2. Parenteral
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2035
    • 13.2.1. Antiplatelet Drugs
    • 13.2.2. Cholesterol-Lowering Drugs (Statins)
    • 13.2.3. Anti-hypertensive Drugs
    • 13.2.4. Blood Pressure Medications
    • 13.2.5. Vasodilators
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Oral
    • 13.3.2. Parenteral
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2035
    • 14.2.1. Antiplatelet Drugs
    • 14.2.2. Cholesterol-Lowering Drugs (Statins)
    • 14.2.3. Anti-hypertensive Drugs
    • 14.2.4. Blood Pressure Medications
    • 14.2.5. Vasodilators
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Oral
    • 14.3.2. Parenteral
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Pfizer Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Eli Lilly and Company
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Cipla
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Lupin
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Viatris Inc
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Johnson & Johnson Services, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Sanofi
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Novartis AG
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Amgen Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Aurobindo Pharma Limited
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Other Prominent Players
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments

List of Tables

  • Table 01: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 02: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 03: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 07: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 08: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country/ Sub-region, 2020-2035
  • Table 10: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 11: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 12: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 15: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 16: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 19: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 20: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 23: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 24: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 02: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 03: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Antiplatelet Drugs, 2020-2035
  • Figure 04: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Cholesterol-Lowering Drugs (Statins), 2020-2035
  • Figure 05: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Anti-hypertensive Drugs, 2020-2035
  • Figure 06: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Blood Pressure Medications, 2020-2035
  • Figure 07: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Vasodilators, 2020-2035
  • Figure 08: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 09: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 10: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 11: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 12: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 13: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 14: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 15: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 16: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 17: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 19: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 20: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 21: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 22: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 23: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 24: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 25: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 26: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 27: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 28: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 29: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 30: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 31: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 32: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 33: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 34: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 35: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 36: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 37: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 38: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 39: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 40: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 41: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 42: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 43: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 44: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 45: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 46: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 47: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 49: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 50: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 51: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 52: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 53: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 54: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 55: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 56: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 57: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 58: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 59: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 60: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 61: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 62: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 63: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 64: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035